Cargando…

Diagnostic Value of Muscle [(11)C] PIB-PET in Inclusion Body Myositis

Background: The accumulation of multiple-protein aggregates within muscle fibers is a pathological hallmark of sporadic inclusion body myositis (s-IBM) with the presence of inclusion bodies. Amyloid-beta is one of the accumulated proteins in s-IBM. The aim of this study was to elucidate the utility...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noto, Yu-ichi, Kondo, Masaki, Tsuji, Yukiko, Matsushima, Shigenori, Mizuno, Toshiki, Tokuda, Takahiko, Nakagawa, Masanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978729/ https://www.ncbi.nlm.nih.gov/pubmed/32010047 http://dx.doi.org/10.3389/fneur.2019.01386

Ejemplares similares

Rate of Changes in CMT Neuropathy and Examination Scores in Japanese Adult CMT1A Patients
por: Kitani-Morii, Fukiko, et al.
Publicado: (2020)

Clinical Impact of PET With (18)F-FDG and (11)C-PIB in Patients With Dementia in a Developing Country
por: Damian, Andres, et al.
Publicado: (2021)

p62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions
por: Watanabe, Yoshihisa, et al.
Publicado: (2012)

Inclusion body myositis: Update on the diagnostic and therapeutic landscape
por: Naddaf, Elie
Publicado: (2022)

Assessment of Amyloid Deposition in Patients With Probable REM Sleep Behavior Disorder as a Prodromal Symptom of Dementia With Lewy Bodies Using PiB-PET
por: Kobayashi, Ryota, et al.
Publicado: (2019)

(11)C-PiB and (124)I-Antibody PET Provide Differing Estimates of Brain Amyloid-β After Therapeutic Intervention
por: Meier, Silvio R., et al.
Publicado: (2022)

[(18)F]FDG, [(11)C]PiB, and [(18)F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline
por: Okonkwo, David O., et al.
Publicado: (2019)

Association Between Treatment-Resistant Sarcoid Myopathy and Inclusion Body Myositis
por: Marotta, Dario A, et al.
Publicado: (2020)

Beevor’s sign in a case of inclusion body myositis
por: Sarraf, Payam, et al.
Publicado: (2021)

Inclusion body myositis: from genetics to clinical trials
por: Nagy, Sara, et al.
Publicado: (2022)

Diagnostic Value of (11)C-PIB PET/MR in Cardiac Amyloidosis
por: Bi, Xiao, et al.
Publicado: (2022)

Can (11)C-PiB-PET Relative Delivery R(1) or (11)C-PiB-PET Perfusion Replace (18)F-FDG-PET in the Assessment of Brain Neurodegeneration?
por: Oliveira, Francisco P.M., et al.
Publicado: (2018)

Impact of a Ketogenic Diet on Sporadic Inclusion Body Myositis: A Case Study
por: Phillips, Matthew C. L., et al.
Publicado: (2020)

A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis
por: Brady, Stefen, et al.
Publicado: (2014)

Distribution of amyloid burden is different between idiopathic normal pressure hydrocephalus and Alzheimer's disease
por: Tokuda, Takahiko, et al.
Publicado: (2015)

Plasma Based Markers of [(11)C] PiB-PET Brain Amyloid Burden
por: Kiddle, Steven John, et al.
Publicado: (2012)

Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS
por: Kasai, Takashi, et al.
Publicado: (2019)

MR-Less Surface-Based Amyloid Assessment Based on (11)C PiB PET
por: Zhou, Luping, et al.
Publicado: (2014)

Negative (11)C-PIB PET Predicts Lack of Alzheimer’s Disease Pathology in Postmortem Examination
por: Scheinin, Noora M., et al.
Publicado: (2018)

Noninvasive Measurement of [(11)C]PiB Distribution Volume Using Integrated PET/MRI
por: Okazawa, Hidehiko, et al.
Publicado: (2020)

Radiological and Laboratory Features of Multiple Sclerosis Patients With Immunosuppressive Therapy: A Multicenter Retrospective Study in Japan
por: Ashida, Shinji, et al.
Publicado: (2021)

Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
por: Ohmichi, Takuma, et al.
Publicado: (2020)

(11)C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn, Young Chul, et al.
Publicado: (2017)

Added Diagnostic Value of (11)C-PiB-PET in Memory Clinic Patients with Uncertain Diagnosis
por: Frederiksen, K.S., et al.
Publicado: (2012)

Identifying Mild Alzheimer's Disease With First 30-Min (11)C-PiB PET Scan
por: Shen, Chushu, et al.
Publicado: (2022)

Quantification of (11)C-PIB kinetics in cardiac amyloidosis
por: Kero, Tanja, et al.
Publicado: (2018)

Quantitative Analysis of PiB-PET with FreeSurfer ROIs
por: Su, Yi, et al.
Publicado: (2013)

Association between cerebrovasoreactivity and stroke in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
por: Mukai, Mao, et al.
Publicado: (2023)

Sonographic Nerve Enlargement in a Patient with Sarcoidosis
por: Kitaoji, Takamasa, et al.
Publicado: (2020)

Quantification and accuracy of clinical [11C]-PiB PET/MRI: the effect of MR-based attenuation correction
por: Law, Ian, et al.
Publicado: (2014)

Diagnostic value of blood thiamine metabolites in Alzheimer’s disease examined by (11)C-PiB PET scanning
por: Chen, Zhichun, et al.
Publicado: (2017)

Multimodal analysis using [(11)C]PiB-PET/MRI for functional evaluation of patients with Alzheimer’s disease
por: Okazawa, Hidehiko, et al.
Publicado: (2020)

Estimation of brain amyloid accumulation using deep learning in clinical [(11)C]PiB PET imaging
por: Ladefoged, Claes Nøhr, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics
por: Kojima, Yuta, et al.
Publicado: (2021)

Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy
por: Kasai, Takashi, et al.
Publicado: (2016)

Update in inclusion body myositis
por: Machado, Pedro, et al.
Publicado: (2013)

Genetics in inclusion body myositis
por: Rothwell, Simon, et al.
Publicado: (2017)

Dysphagia as Isolated Manifestation of Jo-1 Associated Myositis?
por: Labeit, Bendix, et al.
Publicado: (2019)

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology
por: Laforce, Robert, et al.
Publicado: (2014)

CYLD dysregulation in pathogenesis of sporadic inclusion body myositis
por: Yamashita, Satoshi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_af47clf1mvuu4a3av188kfi6pd